A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity.
EBioMedicine
; 60: 102996, 2020 Oct.
Article
in En
| MEDLINE
| ID: mdl-32950002
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Screening Assays, Antitumor
/
Receptor, ErbB-2
/
Antineoplastic Agents, Immunological
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
EBioMedicine
Year:
2020
Document type:
Article
Country of publication:
Países Bajos